To address the growing global health challenge of obesity, which affects more than 1 billion people, the World Health ...

Novo Nordisk says it still thinks GLP-1 drugs could be a promising treatment for Alzheimer’s, despite two disappointing ...

The health agency supports the long-term use of the medications in combination with a healthy diet and exercise, and calls ...

Obesity is the excessive or abnormal accumulation of fat or adipose tissue in the body that impairs health via its ...

FGF19 triggers the brain to burn more energy and activate fat-burning cells, offering a potential new path for obesity ...

The abstract will be published in the peer-reviewed Metabolism: Experimental and Clinical. The presentation will be available on Biomea Fusion's Investor Relations Page under the Events. Please find a ...

Wave Life Sciences stock shot a year-high Monday on promising results for an entirely new mechanism that could target fat ...

Discover why Wave Life Sciences Ltd. is a high-risk, high-reward biotech with unique RNA therapies for AATD, obesity, and ...

This approach offers an enhanced therapeutic effect with minimal systemic toxicity, addressing one of oncology’s ...

Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced the successful inclusion of all five of the Company's self-developed innovative drugs into the updated National Reimbursement Drug List (NRDL ...

Addex Therapeutics Ltd (NASDAQ:ADXN) Q3 2025 Earnings Call Transcript December 4, 2025 Operator: Good day, and thank you for ...

Evercore 8th Annual Healthcare Conference December 3, 2025 10:50 AM ESTCompany ParticipantsDietmar Berger - Chief ...